LAVA Therapeutics N.V. (NASDAQ: LVTX) reported Q2 EPS of ($0.32), $0.02 worse than the analyst estimate of ($0.30).

For earnings history and earnings-related data on LAVA Therapeutics N.V. (LVTX) click here.